Product Watch

ReaMetrix India announces the world

Views: 579

ReaMetrix India Pvt Ltd, a medical diagnostics company based out of Bangalore, today launched the ‘Dry Tri-T Stat’ product used in HIV management, for the global market. This is the only USFDA {FDA 510(K)} cleared dried-down CD4 enumeration product available in the world today for the flow cytometry instrumentation market. This unitized, dried-down delivery format eliminates the need for refrigeration, exhibits nearly 99% correlation with conventional liquid format and is at least three times more affordable than other products existing in the market today. Driven by its vision to effectively address global diagnostic needs in an affordable & accessible manner, ReaMetrix is powered by a cross disciplinary team of engineers, chemists, biologists and doctors and offers innovative solutions in the field of medical diagnostics.

Expressing delight that a company in India has treaded a new, commendable path impacting the global medical diagnostics industry, Dr. Bala Manian, CEO, ReaMetrix, said, ‘ReaMetrix is proud to have pioneered a revolution in global diagnostics. At ReaMetrix, we believe in inverting the conventional thinking by solving the diagnostic needs defined under the constraints of the developing nation context and then deploying these solutions globally. The ‘dried-down’ innovation is a successful validation of our thinking, as this is an innovation that is set to have a global impact.’ According to 2008 estimates, national adult HIV prevalence in India is approximately 0.36 % of total population, that’s nearly 2.5 million people. Currently, there are 197 government Antiretroviral Therapy (ART) centres and some private ART clinics, spread across India where CD4 testing is available (Source: NACO website, ART roll out data as on December 2008). Access to reliable, accurate and affordable CD4 testing solutions, is key in the clinical management of HIV patients. Some of the predominant issues with CD4 testing in the Indian context are the high cost of testing, poor access to testing, poorly developed cold chain for the transport, storage and use of products and a complicated work flow, requiring skilled labor. The real challenge lies in transporting blood samples from remote areas to centralized testing centers. In most cases, this leads to ‘aged’ blood samples (> 48 hrs), making it unusable for testing. ReaMetrix’s innovative dried-down CD4 enumeration product helps address this need. With the unitized, dried down products, the cost of the CD4 enumeration test per patient will see nearly a four-fold reduction in costs, while, at the same time, producing accurate diagnosis. Blood can be collected, stained and fixed at the point of collection before being shipped to a central testing facility at room temperature. Some of the key features of Dry Tri-T Stat are decentralization of sample collection – collect samples at a remote centre before shipment to a central laboratory, processed sample stability – Samples are stable for up to 5-6 days prior to analysis, no cold chain

Recommended from all portals

Latest News

To Top